Lonza
Laëtitia Rodes currently serves as Head of Business Development Biologics on the US East Coast at Lonza, beginning this role in September 2019 after previously holding titles including Director of Regional Account Management and Associate Director of Business Development. Rodes effectively supports clients in biologics development programs, leveraging Lonza's extensive capabilities across various stages of drug development. Prior to Lonza, Rodes was Director of Business Development at IntelGenx Corp., where strategic alliance management and coaching a cross-functional team were key responsibilities. Earlier experience includes management of co-development partnerships and formulation scientist roles aimed at innovative product development. Rodes holds a Ph.D. in Biomedical Engineering from McGill University, an MBA focused on Science and Engineering, and a Master of Science in Engineering, complemented by a brief study at the University of Copenhagen.
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.